| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | group III metabotropic glutamate receptor activity | 7.83e-09 | 4 | 26 | 3 | GO:0001642 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 1.64e-07 | 9 | 26 | 3 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 1.64e-07 | 9 | 26 | 3 | GO:0001640 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 5.61e-06 | 27 | 26 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 7.95e-04 | 884 | 26 | 6 | GO:0004930 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 1.35e-03 | 1353 | 26 | 7 | GO:0004888 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 3.60e-03 | 815 | 26 | 5 | GO:0042803 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 3.86e-03 | 1205 | 26 | 6 | GO:0046983 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 1.16e-07 | 9 | 24 | 3 | GO:0007196 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 7.67e-07 | 16 | 24 | 3 | GO:0007216 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 3.68e-06 | 92 | 24 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | secretion | 5.04e-06 | 1221 | 24 | 9 | GO:0046903 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.54e-05 | 132 | 24 | 4 | GO:0035249 | |
| GeneOntologyBiologicalProcess | secretion by cell | 1.71e-05 | 1064 | 24 | 8 | GO:0032940 | |
| GeneOntologyBiologicalProcess | export from cell | 3.06e-05 | 1153 | 24 | 8 | GO:0140352 | |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 4.31e-05 | 59 | 24 | 3 | GO:0007215 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 6.31e-05 | 67 | 24 | 3 | GO:0099171 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 8.84e-05 | 663 | 24 | 6 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 8.92e-05 | 664 | 24 | 6 | GO:0099177 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.33e-04 | 86 | 24 | 3 | GO:0007193 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 3.42e-04 | 850 | 24 | 6 | GO:0071363 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 4.01e-04 | 125 | 24 | 3 | GO:0051952 | |
| GeneOntologyBiologicalProcess | response to growth factor | 4.20e-04 | 883 | 24 | 6 | GO:0070848 | |
| GeneOntologyBiologicalProcess | triglyceride metabolic process | 4.20e-04 | 127 | 24 | 3 | GO:0006641 | |
| GeneOntologyBiologicalProcess | behavior | 4.40e-04 | 891 | 24 | 6 | GO:0007610 | |
| GeneOntologyBiologicalProcess | regulation of glutamate secretion | 4.47e-04 | 27 | 24 | 2 | GO:0014048 | |
| GeneOntologyBiologicalProcess | neuron projection development | 4.85e-04 | 1285 | 24 | 7 | GO:0031175 | |
| GeneOntologyBiologicalProcess | amine transport | 5.24e-04 | 137 | 24 | 3 | GO:0015837 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 5.56e-04 | 931 | 24 | 6 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 5.56e-04 | 931 | 24 | 6 | GO:0007268 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 5.82e-04 | 939 | 24 | 6 | GO:0099537 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | 7.00e-04 | 1366 | 24 | 7 | GO:0051130 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 7.14e-04 | 976 | 24 | 6 | GO:0099536 | |
| GeneOntologyBiologicalProcess | acylglycerol metabolic process | 7.64e-04 | 156 | 24 | 3 | GO:0006639 | |
| GeneOntologyBiologicalProcess | neutral lipid metabolic process | 7.93e-04 | 158 | 24 | 3 | GO:0006638 | |
| GeneOntologyBiologicalProcess | glutamate secretion | 9.85e-04 | 40 | 24 | 2 | GO:0014047 | |
| GeneOntologyBiologicalProcess | neuron development | 1.05e-03 | 1463 | 24 | 7 | GO:0048666 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.19e-03 | 410 | 24 | 4 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 1.41e-03 | 740 | 24 | 5 | GO:1903530 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.68e-04 | 477 | 26 | 5 | GO:0032279 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 4.09e-04 | 523 | 26 | 5 | GO:0098984 | |
| GeneOntologyCellularComponent | synaptic membrane | 6.71e-04 | 583 | 26 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynapse | 1.31e-03 | 1018 | 26 | 6 | GO:0098794 | |
| Domain | GPCR_3_mtglu_rcpt | 1.33e-07 | 8 | 26 | 3 | IPR000162 | |
| Domain | NCD3G | 6.79e-07 | 13 | 26 | 3 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 6.79e-07 | 13 | 26 | 3 | IPR011500 | |
| Domain | GPCR_3_CS | 8.63e-07 | 14 | 26 | 3 | IPR017979 | |
| Domain | GPCR_3 | 3.13e-06 | 21 | 26 | 3 | IPR000337 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 3.62e-06 | 22 | 26 | 3 | PS50259 | |
| Domain | 7tm_3 | 3.62e-06 | 22 | 26 | 3 | PF00003 | |
| Domain | GPCR_3_C | 3.62e-06 | 22 | 26 | 3 | IPR017978 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 3.62e-06 | 22 | 26 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 3.62e-06 | 22 | 26 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 3.62e-06 | 22 | 26 | 3 | PS00979 | |
| Domain | ANF_receptor | 1.80e-05 | 37 | 26 | 3 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 1.80e-05 | 37 | 26 | 3 | IPR001828 | |
| Domain | Peripla_BP_I | 2.12e-05 | 39 | 26 | 3 | IPR028082 | |
| Domain | - | 5.53e-03 | 261 | 26 | 3 | 1.10.238.10 | |
| Domain | EF-hand-dom_pair | 7.19e-03 | 287 | 26 | 3 | IPR011992 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 7.88e-07 | 15 | 18 | 3 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 7.88e-07 | 15 | 18 | 3 | MM15845 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.32e-05 | 37 | 18 | 3 | MM15067 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.55e-05 | 39 | 18 | 3 | M793 | |
| Pathway | WP_GPCRS_NONODORANT | 1.61e-05 | 266 | 18 | 5 | MM15843 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.22e-04 | 289 | 18 | 4 | MM15057 | |
| Pathway | WP_ADIPOGENESIS | 5.78e-04 | 131 | 18 | 3 | M39505 | |
| Pathway | WP_ADIPOGENESIS_GENES | 6.58e-04 | 137 | 18 | 3 | MM15970 | |
| Pubmed | Distribution of group-III metabotropic glutamate receptors in the retina. | 1.48e-09 | 4 | 26 | 3 | 17311335 | |
| Pubmed | Pias1 interaction and sumoylation of metabotropic glutamate receptor 8. | 7.41e-09 | 6 | 26 | 3 | 16144832 | |
| Pubmed | 1.30e-08 | 7 | 26 | 3 | 9920659 | ||
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 4.43e-08 | 10 | 26 | 3 | 9069281 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 19351574 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 7.43e-07 | 24 | 26 | 3 | 35746896 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 33068816 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 9473604 | ||
| Pubmed | A genome-wide association study for age-related hearing impairment in the Saami. | 3.22e-06 | 4 | 26 | 2 | 20068591 | |
| Pubmed | 5.15e-06 | 45 | 26 | 3 | 25979088 | ||
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 17156446 | ||
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 2.82e-05 | 79 | 26 | 3 | 12679517 | |
| Pubmed | 3.04e-05 | 81 | 26 | 3 | 22723691 | ||
| Pubmed | Replication of recently described type 2 diabetes gene variants in a South Indian population. | 4.17e-05 | 13 | 26 | 2 | 20580033 | |
| Pubmed | 5.38e-05 | 98 | 26 | 3 | 19554387 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 9.35e-05 | 118 | 26 | 3 | 19156168 | |
| Pubmed | 1.19e-04 | 128 | 26 | 3 | 30995482 | ||
| Pubmed | 3.72e-04 | 38 | 26 | 2 | 25613138 | ||
| Pubmed | 5.69e-04 | 47 | 26 | 2 | 32253237 | ||
| Pubmed | 6.96e-04 | 52 | 26 | 2 | 19328558 | ||
| Interaction | GRM4 interactions | 8.07e-05 | 11 | 25 | 2 | int:GRM4 | |
| Interaction | WNT5A interactions | 8.37e-05 | 69 | 25 | 3 | int:WNT5A | |
| Cytoband | 6p21.3 | 8.81e-03 | 250 | 26 | 2 | 6p21.3 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 2.58e-08 | 8 | 15 | 3 | 281 | |
| GeneFamily | Fibronectin type III domain containing | 7.58e-03 | 160 | 15 | 2 | 555 | |
| GeneFamily | WD repeat domain containing | 1.94e-02 | 262 | 15 | 2 | 362 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 1.42e-06 | 200 | 26 | 5 | M6556 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 4.31e-05 | 200 | 26 | 4 | M5566 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN | 4.31e-05 | 200 | 26 | 4 | M6554 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.94e-06 | 186 | 26 | 4 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-06 | 190 | 26 | 4 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.46e-06 | 192 | 26 | 4 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.94e-06 | 197 | 26 | 4 | b8dc192fc98428bbb701cc2ea57fc8ad93397785 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 159 | 26 | 3 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 168 | 26 | 3 | f45dbcd7753117a3e41e1412bce2100d52fa7fd0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-04 | 175 | 26 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.69e-04 | 186 | 26 | 3 | 4e983de6d2515082f9e555f4f949cec84281c140 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 3b8b9161f0fdcbde302ce5b4c0bc874628211109 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | c2101ded71fb16b8ddbc1f883911b1ed2a533ffc | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.85e-04 | 192 | 26 | 3 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 193 | 26 | 3 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 194 | 26 | 3 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 196 | 26 | 3 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 196 | 26 | 3 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.00e-04 | 197 | 26 | 3 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 2.00e-04 | 197 | 26 | 3 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.06e-04 | 199 | 26 | 3 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.06e-04 | 199 | 26 | 3 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.06e-04 | 199 | 26 | 3 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.06e-04 | 199 | 26 | 3 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.06e-04 | 199 | 26 | 3 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.06e-04 | 199 | 26 | 3 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.06e-04 | 199 | 26 | 3 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 200 | 26 | 3 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 200 | 26 | 3 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.09e-04 | 200 | 26 | 3 | 8c803a0ce25e140b46036f6aabefc5502601f408 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.09e-04 | 200 | 26 | 3 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 200 | 26 | 3 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 200 | 26 | 3 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 200 | 26 | 3 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 200 | 26 | 3 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 200 | 26 | 3 | 3bdba9612cd7c612b76aa9abecc4a6529aabfc1c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 200 | 26 | 3 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 200 | 26 | 3 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-ILC|Multiple_Sclerosis / Disease, condition lineage and cell class | 2.09e-04 | 200 | 26 | 3 | ab9bdc9365cbdffe4ed246ce0c8a008a390e387e | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.09e-04 | 200 | 26 | 3 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| Drug | cis-MCG-I | 6.52e-08 | 8 | 25 | 3 | CID003035584 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 9.78e-08 | 9 | 25 | 3 | CID000107216 | |
| Drug | mM PEP | 9.78e-08 | 9 | 25 | 3 | CID005311462 | |
| Drug | AC1N21PP | 9.78e-08 | 9 | 25 | 3 | CID004014619 | |
| Drug | NS-105 | 1.40e-07 | 10 | 25 | 3 | CID000198695 | |
| Drug | cyclobutylene AP5 | 1.92e-07 | 11 | 25 | 3 | CID000126582 | |
| Drug | AC1NSKBB | 3.32e-07 | 13 | 25 | 3 | CID005311256 | |
| Drug | Mspg | 3.32e-07 | 13 | 25 | 3 | CID003964410 | |
| Drug | MSOPPE | 3.32e-07 | 13 | 25 | 3 | CID005311463 | |
| Drug | 2-methyl-6-styrylpyridine | 4.22e-07 | 14 | 25 | 3 | CID000235382 | |
| Drug | MTPG | 4.22e-07 | 14 | 25 | 3 | CID005311456 | |
| Drug | ethylglutamate | 6.49e-07 | 16 | 25 | 3 | CID000014241 | |
| Drug | 2-PMPA | 6.49e-07 | 16 | 25 | 3 | CID010130754 | |
| Drug | 3HPG | 7.87e-07 | 17 | 25 | 3 | CID000001217 | |
| Drug | acromelic acid A | 9.44e-07 | 18 | 25 | 3 | CID000108086 | |
| Drug | aminocyclopentane | 1.12e-06 | 19 | 25 | 3 | CID000002906 | |
| Drug | 4-carboxy-3-hydroxyphenylglycine | 1.32e-06 | 20 | 25 | 3 | CID000001297 | |
| Drug | 3,4-dihydroxyphenylglycine | 1.54e-06 | 21 | 25 | 3 | CID000027915 | |
| Drug | MSOP | 2.04e-06 | 23 | 25 | 3 | CID003964633 | |
| Drug | RS)-2-chloro-5-hydroxyphenylglycine | 2.33e-06 | 24 | 25 | 3 | CID003645780 | |
| Drug | aurintricarboxylic acid | 2.83e-06 | 91 | 25 | 4 | CID000002259 | |
| Drug | AC1NQH9B | 2.99e-06 | 26 | 25 | 3 | CID005221504 | |
| Drug | 1-amino-2-phosphonomethylcyclopropanecarboxylic acid | 3.47e-06 | 3 | 25 | 2 | ctd:C523415 | |
| Drug | PBDA | 4.66e-06 | 30 | 25 | 3 | CID000004408 | |
| Drug | alpha-methyl-4-carboxyphenylglycine | 5.68e-06 | 32 | 25 | 3 | CID000001222 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 6.24e-06 | 33 | 25 | 3 | CID000002071 | |
| Drug | CPPG | 6.84e-06 | 34 | 25 | 3 | CID000002878 | |
| Drug | 1m5d | 7.48e-06 | 35 | 25 | 3 | CID000447082 | |
| Drug | benzyloxyaspartate | 8.87e-06 | 37 | 25 | 3 | CID004133412 | |
| Drug | L-BMAA | 9.62e-06 | 38 | 25 | 3 | CID000028558 | |
| Drug | 4CPG | 9.62e-06 | 38 | 25 | 3 | CID000005115 | |
| Drug | 4-aminopyrrolidine-2,4-dicarboxylate | 1.04e-05 | 39 | 25 | 3 | CID003331970 | |
| Drug | DETC-MeSO | 1.04e-05 | 39 | 25 | 3 | CID003035711 | |
| Drug | L000369 | 1.21e-05 | 41 | 25 | 3 | CID003931705 | |
| Drug | AC1NNRU4 | 1.21e-05 | 41 | 25 | 3 | CID005126051 | |
| Drug | butenafine | 1.31e-05 | 42 | 25 | 3 | CID000002484 | |
| Drug | LY341495 | 1.40e-05 | 43 | 25 | 3 | CID006324636 | |
| Drug | Joro spider toxin | 1.40e-05 | 43 | 25 | 3 | CID000119582 | |
| Drug | DE gel | 1.70e-05 | 143 | 25 | 4 | CID000008146 | |
| Drug | cysteine sulfinic acid | 1.72e-05 | 46 | 25 | 3 | CID000000109 | |
| Drug | AC1MBZ3L | 1.73e-05 | 6 | 25 | 2 | CID002733524 | |
| Drug | phorbol 12,13-diacetate | 1.96e-05 | 48 | 25 | 3 | CID000072293 | |
| Drug | methylenecyclopropylglycine | 2.08e-05 | 49 | 25 | 3 | CID000441452 | |
| Drug | L-CCG-I | 2.22e-05 | 50 | 25 | 3 | CID000001271 | |
| Drug | LY354740 | 2.35e-05 | 51 | 25 | 3 | CID000114827 | |
| Drug | AC1L1EKQ | 2.49e-05 | 52 | 25 | 3 | CID000002834 | |
| Drug | N-Ac-D-E | 2.64e-05 | 53 | 25 | 3 | CID000005255 | |
| Drug | 2-phenylglycine | 2.95e-05 | 55 | 25 | 3 | CID000003866 | |
| Drug | GYKI 52466 | 3.47e-05 | 58 | 25 | 3 | CID000003538 | |
| Drug | MPEP | 3.65e-05 | 59 | 25 | 3 | CID003025961 | |
| Drug | 1,2-diglyceride | 3.76e-05 | 175 | 25 | 4 | CID000192866 | |
| Drug | 3,5-dihydroxyphenylglycine | 3.84e-05 | 60 | 25 | 3 | CID000108001 | |
| Drug | pyrrolidine-2,4-dicarboxylate | 4.04e-05 | 61 | 25 | 3 | CID000003868 | |
| Drug | homocysteic acid | 5.11e-05 | 66 | 25 | 3 | CID000092117 | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 5.51e-05 | 193 | 25 | 4 | 4241_DN | |
| Drug | DCG-IV | 5.59e-05 | 68 | 25 | 3 | CID000115114 | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 6801_UP | |
| Drug | Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; HL60; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 2343_DN | |
| Drug | felbamate | 6.10e-05 | 70 | 25 | 3 | CID000003331 | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 5471_UP | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 5575_DN | |
| Drug | colchicine; Up 200; 0.1uM; MCF7; HG-U133A | 6.32e-05 | 200 | 25 | 4 | 644_UP | |
| Drug | norbiotin | 6.63e-05 | 72 | 25 | 3 | CID000446903 | |
| Drug | AC1L9FMM | 6.91e-05 | 73 | 25 | 3 | CID000444055 | |
| Drug | AC1L1DME | 7.49e-05 | 75 | 25 | 3 | CID000002414 | |
| Drug | AMN082 | 7.59e-05 | 12 | 25 | 2 | CID001894360 | |
| Drug | 2-amino-3-phosphonopropionic acid | 7.80e-05 | 76 | 25 | 3 | CID000003857 | |
| Drug | D-N-Q | 1.05e-04 | 84 | 25 | 3 | CID000003140 | |
| Drug | AC1L1BXF | 1.09e-04 | 85 | 25 | 3 | CID000001650 | |
| Drug | memantine | 1.13e-04 | 86 | 25 | 3 | CID000004054 | |
| Drug | IPSP | 1.17e-04 | 87 | 25 | 3 | CID000022083 | |
| Drug | NSC298883 | 1.25e-04 | 89 | 25 | 3 | CID000326807 | |
| Drug | HA1 100 | 1.29e-04 | 90 | 25 | 3 | CID003064778 | |
| Drug | hexachlorophene | 1.29e-04 | 90 | 25 | 3 | CID000003598 | |
| Drug | 2-amino-4-phosphonobutyric acid | 1.33e-04 | 91 | 25 | 3 | CID000002207 | |
| Drug | AC1Q3ZOL | 1.69e-04 | 258 | 25 | 4 | CID000002376 | |
| Drug | cyclothiazide | 1.92e-04 | 103 | 25 | 3 | CID000002910 | |
| Drug | BUMP | 1.96e-04 | 19 | 25 | 2 | CID003034171 | |
| Drug | EN-1530 | 2.25e-04 | 278 | 25 | 4 | CID000004425 | |
| Drug | 1-aminocyclopentane-1,3-dicarboxylate | 2.40e-04 | 111 | 25 | 3 | CID000001310 | |
| Drug | ibotenic acid | 3.17e-04 | 122 | 25 | 3 | CID000001233 | |
| Drug | kynurenic acid | 3.17e-04 | 122 | 25 | 3 | CID000003845 | |
| Drug | pSer | 3.48e-04 | 126 | 25 | 3 | CID000000106 | |
| Drug | thiourea | 3.65e-04 | 128 | 25 | 3 | CID002723790 | |
| Drug | AP-5 | 3.65e-04 | 128 | 25 | 3 | CID000001216 | |
| Drug | aniracetam | 3.82e-04 | 130 | 25 | 3 | CID000002196 | |
| Drug | ethyl acetate | 4.45e-04 | 137 | 25 | 3 | CID000008857 | |
| Drug | ganciclovir | 4.74e-04 | 140 | 25 | 3 | CID000003454 | |
| Drug | 8-CPT-cAMP | 5.15e-04 | 144 | 25 | 3 | CID000001903 | |
| Drug | AC1L63MU | 5.21e-04 | 347 | 25 | 4 | CID000285703 | |
| Drug | Dantrolene-13C3 | 5.25e-04 | 145 | 25 | 3 | CID000002951 | |
| Drug | nimodipine | 5.25e-04 | 145 | 25 | 3 | CID000004497 | |
| Drug | Rotenone | 5.43e-04 | 978 | 25 | 6 | ctd:D012402 | |
| Drug | chelerythrine | 5.79e-04 | 357 | 25 | 4 | CID000002703 | |
| Drug | oriens | 6.26e-04 | 154 | 25 | 3 | CID000161645 | |
| Drug | Anidulafungin | 6.62e-04 | 157 | 25 | 3 | CID000166548 | |
| Drug | 3-bromo-7-nitroindazole | 7.13e-04 | 36 | 25 | 2 | CID000001649 | |
| Drug | MPTP-HCl | 7.25e-04 | 162 | 25 | 3 | CID000001388 | |
| Drug | Aspartylglutamate | 8.80e-04 | 40 | 25 | 2 | CID000151403 | |
| Drug | riluzole | 8.92e-04 | 174 | 25 | 3 | CID000005070 | |
| Disease | nodular sclerosis Hodgkin lymphoma | 6.23e-05 | 14 | 25 | 2 | EFO_0004708 | |
| Disease | uterine fibroid measurement | 2.76e-04 | 29 | 25 | 2 | EFO_0009410 | |
| Disease | asthma | 3.67e-04 | 751 | 25 | 5 | MONDO_0004979 | |
| Disease | Osteosarcoma | 7.28e-04 | 47 | 25 | 2 | C0029463 | |
| Disease | Eczema, allergic rhinitis | 7.79e-04 | 215 | 25 | 3 | EFO_0005854, HP_0000964 | |
| Disease | generalised epilepsy | 8.90e-04 | 52 | 25 | 2 | EFO_0005917 | |
| Disease | allergic disease | 1.32e-03 | 258 | 25 | 3 | MONDO_0005271 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.47e-03 | 67 | 25 | 2 | EFO_0008595, EFO_0020946 | |
| Disease | nephrotic syndrome | 1.65e-03 | 71 | 25 | 2 | EFO_0004255 | |
| Disease | Hodgkins lymphoma | 2.20e-03 | 82 | 25 | 2 | EFO_0000183 | |
| Disease | Eczema | 2.23e-03 | 310 | 25 | 3 | HP_0000964 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSDNWMDRFRNAYVW | 81 | P56851 | |
| DIIRVFFKDNEDWWY | 1076 | Q8N157 | |
| NRRNIWFAEFWEDNF | 356 | Q14833 | |
| RDWNDMERIWQYVYS | 81 | P42025 | |
| ELMQFGDREFYRDWW | 351 | O75907 | |
| WQEFVLEMRFRWENN | 481 | Q15042 | |
| ANFDFDVWRKKYMRW | 3151 | O94854 | |
| TDFRSDRLWEMYINW | 201 | Q86UA1 | |
| SWANWMRYVNCARDD | 311 | Q9NQV7 | |
| FYEQAFRDQWERSWV | 556 | Q9UP38 | |
| WAQWDMSEQRLYYID | 211 | A4D1B5 | |
| NRRNIWFAEFWEENF | 351 | O15303 | |
| ENNRRNVWFAEYWEE | 356 | Q14831 | |
| DFNRDWLDWMYTFSR | 271 | Q9BSE4 | |
| VYDFWRMIWQEQSAC | 966 | Q15262 | |
| CDYRANQWAWMTRDL | 246 | Q17RP2 | |
| WRQIFDEEYNVWFLD | 601 | Q9UPU3 | |
| VRFFYDFLWRDWDDE | 256 | Q9BZQ2 | |
| RNYTFWQWFDGVMEV | 566 | P51692 | |
| MDGQTDFWRDWEDYA | 4076 | P22105 | |
| EEMQRQARWFWEAYF | 386 | Q93063 | |
| YWNRFRDDDYFRNWN | 56 | Q08629 | |
| RWWNAYILFYEQMDM | 1946 | O00507 | |
| WYWCGIQRDFARDDM | 151 | P0DMS9 | |
| LDWTMQAYERNFWDP | 251 | Q9HAD4 | |
| RLDWLMWFAAFQTYE | 461 | Q96S06 |